gantenerumab
Sign in to saveGantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease being developed by Hoffmann-La Roche pharmaceuticals.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease being developed by Hoffmann-La Roche pharmaceuticals.
Gantenerumab binds to and clears aggregated beta amyloid fibers.
Excerpted from Wikipedia’s “gantenerumab” article, available under the CC BY-SA 4.0 licence.